添加微信 添加微信
添加微信
首页: 全球医药政策

英国-F-star

时间:2021-10-21 18:23:56 来源:康安医药咨询 作者:康安医药咨询

F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies with the goal of creating a paradigm-shift in cancer therapy F-star is a biopharmaceutical company focused on developing immuno-oncology bispecific antibody therapeutics. We are committed to delivering life-changing treatments to those patients with cancer who are not well-served by current therapies through the application of our Modular Antibody Technology™ platform.

Phone: 44-1223-497400 E-mail: cambridge@f-star.com
Web: http://www.f-star.com
Add:Eddeva B920, Babraham Research Campus, Cambridge, CB22 3AT, UK

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章